08/23/2024 3:15 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 3:48 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:34 PM | Clyburn Frank (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/07/2024 4:34 PM | Clyburn Frank (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:07 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 424B5 | |
08/02/2024 4:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 3:29 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/16/2024 4:05 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 3:27 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 7:03 AM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 3:35 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:36 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:36 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 3:36 PM | Patel Sushil (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 3:36 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2024 3:19 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:19 PM | Patel Sushil (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024 4:05 PM | Horning Sandra (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024 4:06 PM | Patel Sushil (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024 4:06 PM | Borisy Alexis (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024 4:07 PM | Kim Lorence H. (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024 4:07 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024 4:08 PM | Borellini Flavia (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/28/2024 4:09 PM | ANDERSON ELIZABETH M (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4/A | |
06/27/2024 5:48 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:20 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 3:20 PM | ANDERSON ELIZABETH M (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:20 PM | Borellini Flavia (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:20 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Weber Barbara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:21 PM | Kim Lorence H. (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:21 PM | Borisy Alexis (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:22 PM | Patel Sushil (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:23 PM | Horning Sandra (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 10:28 AM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:47 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:37 PM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) Wei Lin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:20 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:08 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 3:56 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 3:31 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:18 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
"Doomsday indicator” flashing for the first time since the Great Depression... (Ad) It's been a bloodbath in the markets.
The seven most valuable US tech companies lost a combined $1 trillion - in a single day.
And things could get a lot worse...![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9490&Placement=NativeDisplay&Source=NativeDisplay) Click here to discover how Wall Street insiders are quietly preparing for a market crash >>> |
06/03/2024 3:40 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024 3:31 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 4:11 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form S-3ASR | |
05/03/2024 6:36 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 3:30 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEF 14A | |
04/25/2024 3:35 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form DEFA14A | |
04/12/2024 7:08 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 3:23 PM | Patel Sushil (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 3:21 PM | Patel Sushil (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024 3:57 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wei Lin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/27/2024 3:24 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:43 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:44 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:44 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:45 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:45 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:50 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:10 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:21 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 4:04 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:48 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 3:32 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:30 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 3:52 PM | Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer) Wang Xiaolin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:53 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:54 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:54 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 3:55 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:30 PM | EcoR1 Capital, LLC (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/14/2024 8:26 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/13/2024 5:06 AM | BB BIOTECH AG (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 4:11 PM | Farallon Capital Partners, L.P. (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/09/2024 4:22 PM | COLUMN GROUP III, LP (Filed by) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form SC 13G/A | |
02/08/2024 9:17 AM | Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/22/2024 3:18 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:26 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 1:15 PM | Revolution Medicines (Filer) Revolution Medicines, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:06 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:31 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/29/2023 3:14 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:22 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 4:07 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:08 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:08 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:10 PM | Anders Jack (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 6:30 PM | Horn Margaret A (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:35 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
12/14/2023 5:38 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144/A | |
12/14/2023 4:55 PM | GOLDSMITH MARK A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 5:14 PM | Kelsey Stephen Michael (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 5:22 PM | Anders Jack (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:48 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 4:37 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 3:33 PM | Horn Margaret A (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023 5:24 PM | Cislini Jeff (Reporting) Revolution Medicines (Issuer) Revolution Medicines, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:14 PM | Cislini Jeff (Reporting) Revolution Medicines (Subject) Revolution Medicines, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |